SEC Form 4 · accession 0001179110-15-013103
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn Sblendorio
Officer — President & CFO · Director
Period of report
Sep 3, 2015
Accepted (ET)
Sep 4, 2015 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 3, 2015 | M | 25,000 | $22.04 | A | 124,805 | D | |
| Common StockF1 | Sep 3, 2015 | S | 25,000 | $42.00 | D | 99,805 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy)F3,F2 | $22.04 | Sep 3, 2015 | M | 25,000 | D | — | Feb 24, 2022 | Common Stock | 25,000 | 43,000 | D |
Explanation of responses
- F1Sales were effected pursuant to a Rule 10b5-1 program adopted by the reporting person.
- F2This option vested in forty-eight equal installments beginning on March 24, 2012.
- F3Not applicable.